Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy

被引：0
|
作者：
Vojtech Kratky
Anna Valerianova
Zdenka Hruskova
Vladimir Tesar
Jan Malik
机构：
[1] Charles University and General University Hospital in Prague,Department of Nephrology, First Faculty of Medicine
[2] Charles University and General University Hospital in Prague,3rd Department of Internal Medicine, First Faculty of Medicine
来源：
Current Atherosclerosis Reports | 2024年 / 26卷
关键词：
Cardiovascular Disease; Vascular Pathology; Chronic Kidney Disease; Dyslipidemia; Lipid-lowering Drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：103 / 109
页数：6
相关论文
共 50 条
  • [1] Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
    Kratky, Vojtech
    Valerianova, Anna
    Hruskova, Zdenka
    Tesar, Vladimir
    Malik, Jan
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (04) : 103 - 109
  • [2] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [3] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [4] Do patients with CKD benefit from lipid-lowering therapy?
    Holdaas, Hallvard
    Jardine, Alan
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (12) : 684 - 685
  • [5] Do patients with CKD benefit from lipid-lowering therapy?
    Hallvard Holdaas
    Alan Jardine
    Nature Reviews Nephrology, 2012, 8 : 684 - 685
  • [6] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [7] Preventing cardiovascular outcome in patients with renal impairment: Is there a role for lipid-lowering therapy?
    Holdaas H.
    American Journal of Cardiovascular Drugs, 2005, 5 (4) : 255 - 269
  • [8] Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients
    Kaysen, George A.
    BLOOD PURIFICATION, 2017, 43 (1-3) : 196 - 199
  • [9] LIPID-LOWERING THERAPY AMONG CKD PATIENTS IN AUSTRALIAN GENERAL PRACTICE
    Khanam, M. A.
    Radford, J.
    Castelino, R.
    Jose, M. D.
    Kitsos, A.
    Stankovich, J.
    Zaidi, S. T.
    Kinsman, L.
    Peterson, G. M.
    NEPHROLOGY, 2017, 22 : 38 - 38
  • [10] Atherosclerotic cardiovascular risk and simulation of lipid-lowering therapy in China
    Bi, L. E. I.
    Yi, J. Y.
    Wu, C. Q.
    Lu, J. P.
    Zhang, H. B.
    Yang, Y. A. N. G.
    Li, X. I.
    Zheng, X. I. N.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2567 - 2567
12345